APA (7th ed.) Citation

Cassimon, D., De Backer, M., Engelen, P., Van Wouwe, M., & Yordanov, V. (2011). Incorporating technical risk in compound real option models to value a pharmaceutical R&D licensing opportunity. Research Policy, 40(9), 1200. https://doi.org/10.1016/j.respol.2011.05.020

Chicago Style (17th ed.) Citation

Cassimon, D., M. De Backer, P.J Engelen, M. Van Wouwe, and V. Yordanov. "Incorporating Technical Risk in Compound Real Option Models to Value a Pharmaceutical R&D Licensing Opportunity." Research Policy 40, no. 9 (2011): 1200. https://doi.org/10.1016/j.respol.2011.05.020.

MLA (9th ed.) Citation

Cassimon, D., et al. "Incorporating Technical Risk in Compound Real Option Models to Value a Pharmaceutical R&D Licensing Opportunity." Research Policy, vol. 40, no. 9, 2011, p. 1200, https://doi.org/10.1016/j.respol.2011.05.020.